LIVER GROWTH FACTOR: GENE CLONING AND EXPRESSION

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$48,760.00
Award Year:
1990
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
13809
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Genetic Therapy Inc
19 Firstfield Rd, Gaithersburg, MD, 20878
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Paul Tolstoshev
(301) 590-2626
Business Contact:
() -
Research Institution:
n/a
Abstract
THE HUMAN CDNA FOR HEPATOPOIETIN A WILL BE ISOLATED, USING PUBLISHED SEQUENCE DATA, AND WILL BE INSERTED INTO A RETROVIRAL VECTOR CAPABLE OF EXPRESSING THE GENE IN MAMMALIAN CELLS. THE VECTOR WILL BE INTRODUCED INTO A VARIETY OF MAMMALIAN CELLS, INCLUDING FIBROBLASTS AND HEPATOCYTES, TO MEASURE THE LEVELS OF EXPRESSION OF THE INTRODUCED HEPATOPOIETIN A GENE. BIOLOGICAL ACTIVITY, AS WELL AS THE PHYSICAL PROPERTIES OF THE PRODUCT, WILL BE USEDTO MONITOR EXPRESSION OF THE ACTIVE PRODUCT. BECAUSE HEPATOPOIETIN A IS NOW KNOWN TO BE POSTTRANSITIONALLY MODIFIED BY GLYCOSYLATION, EXPRESSION IN MAMMALIAN CELLS WILL BE USED, RATHER THAN ATTEMPTING TO EXPRESS THE PRODUCT IN ESCHERICHIA COLI. THE PROTEIN PRODUCT, FROM AN OPTIMIZED MAMMALIAN EXPRESSION SYSTEM, WILL BE USED TO TEST THE EFFECTS OF THIS GROWTH FACTOR ON LIVER CELLS AND OTHER CELLS IN VITRO, AS WELL AS ITS EFFECTSIN VIVO IN ANIMAL SYSTEMS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government